ERBB2 and invasive breast carcinoma: HER2 and HR characterize the expression of human epidermal growth factor receptor 2 and hormone receptor based on IHC staining of surgical specimens and are widely used biomarkers for invasive breast cancer for treatment selection and response prediction [3].